Cover Image

On the Calibration of Bayesian Success Criteria and Operating Characteristics for Clinical Trials

Fuente: arXiv

Saved in:

Bibliographic Details
Main Authors:	Yang, Peng, Wang, Li, Yuan, Ying
Format:	Preprint
Published:	2026
Subjects:	Methodology Applications
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SIMBA -- A Bayesian Decision Framework for the Identification of Optimal Biomarker Subgroups for Cancer Basket Clinical Trials
by: Yuan, Shijie, et al.
Published: (2025)

Adjusting for Selection Bias Due to Missing Eligibility Criteria in Emulated Target Trials
by: Benz, Luke, et al.
Published: (2024)

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
by: Komaki, Moka, et al.
Published: (2025)

Elastic Bayesian Model Calibration
by: Francom, Devin, et al.
Published: (2023)

A Bayesian Discrete Framework for Enhancing Decision-Making Processes in Clinical Trial Designs and Evaluations
by: Pramanik, Paramahansa, et al.
Published: (2026)

BMW: Bayesian Model-Assisted Adaptive Phase II Clinical Trial Design for Win Ratio Statistic
by: Zhu, Di, et al.
Published: (2026)

Priors from Envisioned Posterior Judgments: A Novel Elicitation Approach With Application to Bayesian Clinical Trials
by: Ouyang, Yongdong, et al.
Published: (2024)

MUCE: Bayesian Hierarchical Modeling for the Design and Analysis of Phase 1b Multiple Expansion Cohort Trials
by: Lyu, Jiaying, et al.
Published: (2020)

Bayesian Design and Analysis of Precision Trials with Partial Borrowing
by: Golchi, Shirin, et al.
Published: (2026)

Is Repeated Bayesian Interim Analysis Consequence-Free?
by: Liu, Suyu, et al.
Published: (2025)

Bayesian Spatial Point Process Modeling for Cluster Randomized Trials
by: Lee, Jooyeon, et al.
Published: (2025)

Statistical Inference for Heterogeneous Treatment Effect with Right-censored Data from Synthesizing Randomized Clinical Trials and Real-world Data
by: Mao, Guangcai, et al.
Published: (2025)

Simulation-based Calibration of Uncertainty Intervals under Approximate Bayesian Estimation
by: Savitsky, Terrance D., et al.
Published: (2024)

Dynamic Prediction of the Target Survival Time in Metastatic Solid Tumor Cancer Clinical Trials
by: Wang, Sidi, et al.
Published: (2026)

[Invited Discussion] Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions
by: Phillips, Rachael V., et al.
Published: (2024)

E-values for Adaptive Clinical Trials: Anytime-Valid Monitoring in Practice
by: Sokolova, Alexandra, et al.
Published: (2026)

Heterogeneous Clinical Trial Outcomes via Multi-Output Gaussian Processes
by: Thomas, Owen, et al.
Published: (2024)

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials
by: Maity, Arnab Kumar, et al.
Published: (2024)

Correcting for Missing Data When Evaluating Surrogate Markers in a Clinical Trial
by: Lotspeich, Sarah C., et al.
Published: (2026)

A Bayesian Framework for Latent Compliance Modeling in Cluster Randomized Trials with One-Sided Noncompliance
by: Sisti, Anthony, et al.
Published: (2025)

Identifying Treatment Effect Heterogeneity with Bayesian Hierarchical Adjustable Random Partition in Adaptive Enrichment Trials
by: Zhao, Xianglin, et al.
Published: (2025)

A Workflow for Evaluating Regional Treatment Effect Heterogeneity in Multi-Regional Clinical Trials
by: Zhang, Cong, et al.
Published: (2026)

Semiparametric Piecewise Accelerated Failure Time Model for the Analysis of Immune-Oncology Clinical Trials
by: Sunami, Hisato, et al.
Published: (2024)

Risk-Calibrated Process Capability Approval with Finite Samples
by: Jiang, Fei, et al.
Published: (2026)

Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data
by: Lee, Kyong Ju, et al.
Published: (2025)

Monitoring Adverse Events Through Bayesian Nonparametric Clustering Across Studies
by: Yuan, Shijie, et al.
Published: (2025)

Covariate Ordered Systematic Sampling as an Improvement to Randomized Controlled Trials
by: Jobson, Deddy, et al.
Published: (2024)

Study Duration Prediction for Clinical Trials with Time-to-Event Endpoints Using Mixture Distributions Accounting for Heterogeneous Population
by: Zhang, Hong, et al.
Published: (2023)

Robust Causal Inference for EHR-based Studies of Point Exposures with Missingness in Eligibility Criteria
by: Benz, Luke, et al.
Published: (2025)

Uncovering Treatment Effect Heterogeneity in Pragmatic Gerontology Trials
by: Li, Changjun, et al.
Published: (2025)

Bayesian shape-constrained regression for quantifying Alzheimer's disease biomarker progression
by: Li, Mingyuan, et al.
Published: (2025)

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties
by: Cui, Ying, et al.
Published: (2025)

Toward Valid Generative Clinical Trial Data with Survival Endpoints
by: Chassat, Perrine, et al.
Published: (2025)

Designing Efficient Hybrid and Single-Arm Trials: External Control Borrowing and Sample Size Calculation
by: Gao, Yujing, et al.
Published: (2025)

Index Date Imputation For Survival Outcomes for Externally Controlled Trials
by: Coent, Q. Le, et al.
Published: (2025)

On the Consistency of Bayesian Adaptive Testing under the Rasch Model
by: Yang, Hau-Hung, et al.
Published: (2024)

Bayesian sequential analysis of adverse events with binary data
by: Wang, Jiayue, et al.
Published: (2025)

Flexible Bayesian Tensor Decomposition for Verbal Autopsy Data
by: Zhu, Yu, et al.
Published: (2025)

JASPER: Joint Bayesian Analysis of Spatial Expression via Regression
by: Dey, Pritam, et al.
Published: (2026)

Strategic decision points in experiments: A predictive Bayesian optional stopping method
by: Yang, Xiaomi, et al.
Published: (2025)